Table 2 The mean scores of the MG-ADL, MGC, QMG and MG-QOL15r at baseline and during follow-up in both treatment groups.
Clinical scores | Efgartigimod (n = 9) | *P value | IVIg (n = 10) | #P value | |
|---|---|---|---|---|---|
Baseline | MG-ADL score, mean ± SD | 13.78 ± 4.18 | – | 11.00 ± 3.62 | – |
MGC score, mean ± SD | 26.44 ± 6.15 | – | 20.80 ± 7.16 | – | |
QMG score, mean ± SD | 19.00 ± 5.03 | – | – | – | |
MG-QOL15r score, mean ± SD | 32.11 ± 9.33 | – | – | – | |
Week 1 | MG-ADL score, mean ± SD | 7.11 ± 7.13 | 0.002 | 8.00 ± 3.40 | < 0.001 |
MGC score, mean ± SD | 12.89 ± 12.34 | 0.004 | 15.00 ± 6.58 | 0.002 | |
QMG score, mean ± SD | 11.63 ± 6.74 | 0.001 | – | – | |
MG-QOL15r score, mean ± SD | 20.63 ± 15.78 | 0.017 | – | – | |
Week 2 | MG-ADL score, mean ± SD | 5.57 ± 6.48 | < 0.001 | – | – |
MGC score, mean ± SD | 11.50 ± 12.29 | 0.003 | – | – | |
QMG score, mean ± SD | 9.57 ± 7.64 | 0.002 | – | – | |
MG-QOL15r score, mean ± SD | 14.75 ± 15.10 | 0.003 | – | – | |
Week 3 | MG-ADL score, mean ± SD | 4.25 ± 5.50 | < 0.001 | – | – |
MGC score, mean ± SD | 10.13 ± 11.10 | 0.002 | – | – | |
QMG score, mean ± SD | 8.83 ± 8.50 | 0.010 | – | – | |
MG-QOL15r score, mean ± SD | 12.88 ± 12.74 | 0.001 | – | – | |
Week 4 | MG-ADL score, mean ± SD | 2.67 ± 3.32 | < 0.001 | 4.20 ± 2.10 | < 0.001 |
MGC score, mean ± SD | 7.22 ± 9.09 | < 0.001 | 7.30 ± 4.47 | < 0.001 | |
QMG score, mean ± SD | 7.67 ± 6.71 | 0.001 | – | – | |
MG-QOL15r score, mean ± SD | 8.88 ± 10.45 | < 0.001 | – | – | |
